CRO Services with Expertise in Diabetes, NAFLD/NASH, and Obesity

Get in Touch

Science-Driven. Focused. Dedicated.

ProSciento has supported research for the advancement of nearly all medically relevant drug classes and devices for diabetes, NASH, and obesity and contributed to the evolution of advanced methods for nearly two decades.

350+

Clinical trials completed in diabetes, NASH & obesity

17

Contributions to 17 approved metabolic drugs and devices

19+

Years as the leading clinical research provider for metabolic diseases

DIABETES

Unparalleled clinical research expertise in type 1 and type 2 diabetes

Learn More

NASH

(Nonalcoholic Steatohepatitis)

Accelerating drug development and advancing biomarker research for NAFLD and NASH

Learn More

doctor reviewing information with a graphical representation of a liver

OBESITY

Advancing obesity drug development through unparalleled metabolic expertise

Learn More

Obesity patient consulting with a physician

About Us
- Overview
- Leadership
- Corporate Values
- News
- Events
Metabolic Focus
Services
Specialized Methods
Publication Library
Careers
Enroll in Study
Join Our Site Network
Contact Us